β-Carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 55 (2) , 179-184
- https://doi.org/10.1016/0304-3940(85)90016-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Etiology of Parkinson’s Disease: A Research StrategyCanadian Journal of Neurological Sciences, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Identification and quantification of 1,2,3,4-tetrahydro-β-carboline, 2-methyl-1,2,3,4-tetrahydro-β-carboline, and 6-methoxy-1,2,3,4-tetrahydro-β-carboline as in vivo constituents of rat brain and adrenal glandBiochemical Pharmacology, 1981
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis ratesBrain Research, 1979
- A FURTHER INSIGHT INTO THE METABOLISM OF CERTAIN βCARBOLINESAnnals of the New York Academy of Sciences, 1973
- Metabolism of 6-Methoxytetrahydro-β-Carboline in RatsXenobiotica, 1972